# Evaluating the Impact of Scanner Harmonisation with ComBat on Longitudinal Brain Volume Measures in Huntington’s Disease

29 Oct 26

publications

# Evaluating the Impact of Scanner Harmonisation with ComBat on Longitudinal Brain Volume Measures in Huntington’s Disease

Rebecca White

[  ](https://x.com/intent/tweet?url=https://ixico.com/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) [  ](https://bsky.app/intent/compose?text=https://ixico.com/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) [  ](https://www.facebook.com/sharer/sharer.php?u=https://ixico.com/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) [  ](https://www.linkedin.com/shareArticle?mini=true&url=https://ixico.com/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) <a class="trigger-share-window d-md-none">  </a>

![EHDN 2026 Poster](/assets/blog-images/EHDN-2026-Poster__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) <a class="squishy-button" href=""> Download the poster  </a>

Regional brain atrophy is an important marker of disease progression in Huntington’s disease (HD). However, multicentre studies often collect MRI data using different scanners, which can introduce variability and make it harder to distinguish genuine biological change from scanner-related effects.

This study investigated whether longitudinal ComBat, a statistical harmonisation method designed to reduce scanner-related differences, could improve the sensitivity of brain volume measurements to HD progression. Using  IXITM regional segmentation algorithms and boundary shift integral, researchers analysed the caudate, putamen, whole brain and lateral ventricles in 482 healthy controls and 918 participants spanning different stages of Huntington’s disease. Data were drawn from the Track-/TrackOn-HD, Predict-HD and Image-HD studies.

While harmonisation reduced some scanner-related variability, it did not improve sensitivity to disease progression, and disease-related effect sizes were reduced in most cases after harmonisation. The findings highlight an important consideration for longitudinal neuroimaging studies: reducing technical variability may also risk reducing meaningful biological signal, underlining the importance of carefully evaluating harmonisation approaches when developing imaging biomarkers.

<a class="squishy-button" href=""> Download the poster  </a>

[ Back to Scientific Publications  ](/news-and-resources/publications/)

### Recents

![Neuromelanin-Sensitive MRI of the Substantia Nigra: Comparing TSE and MT-GRE Contrast](/assets/blog-images/ESMRMB-2026__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp)

1 Oct 26

publications

[Neuromelanin-Sensitive MRI of the Substantia Nigra: Comparing TSE and MT-GRE Contrast](/news-and-resources/publications/contrast-ratio-assessment-of-the-substantia-nigra-in-neuromelanin-sensitive-mri/)

[Improving Neuromelanin-sensitive MRI measurement ](/news-and-resources/publications/improving-neuromelanin-sensitive-mri-measurement/)

[Further validation of IXI technology platform automation capabilities](/news-and-resources/publications/further-validation-of-ixi-technology-platform-automation-capabilities/)

[Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology](/news-and-resources/publications/interchangeability-of-blood-based-biomarkers-and-pet-to-identify-alzheimers-disease-pathology/)

[Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography](/news-and-resources/publications/biomarkers-in-patients-with-clinical-signs-of-mild-cognitive-impairment-or-mild-alzheimers-disease-but-without-amyloid-deposits-on-positron-emission-tomography/)

### Library

[October 2026](/news-and-resources/publications/archive/2026/10/)

[September 2026](/news-and-resources/publications/archive/2026/09/)

[July 2026](/news-and-resources/publications/archive/2026/07/)

[June 2026](/news-and-resources/publications/archive/2026/06/)

[May 2026](/news-and-resources/publications/archive/2026/05/)

[April 2026](/news-and-resources/publications/archive/2026/04/)

[March 2026](/news-and-resources/publications/archive/2026/03/)

[February 2026](/news-and-resources/publications/archive/2026/02/)

[January 2026](/news-and-resources/publications/archive/2026/01/)

[2025](/news-and-resources/publications/archive/2025/)

[2024](/news-and-resources/publications/archive/2024/)

[2023](/news-and-resources/publications/archive/2023/)

[2022](/news-and-resources/publications/archive/2022/)

[2021](/news-and-resources/publications/archive/2021/)

[2020](/news-and-resources/publications/archive/2020/)

[2019](/news-and-resources/publications/archive/2019/)